• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Postgraduate Medical Journal >New insulins and newer insulin regimens: a review of their role in improving glycaemic control in patients with diabetes
【24h】

New insulins and newer insulin regimens: a review of their role in improving glycaemic control in patients with diabetes

机译：新的胰岛素和新的胰岛素治疗方案：它们在改善糖尿病患者血糖控制中的作用综述

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The legacy effect of early good glycaemic control in people with diabetes shows it is associated with reduction of microvascular and macrovascular complications. Insulin therapy is essential and lifesaving in individuals with type 1 diabetes and beneficial for those with type 2 diabetes who fail to achieve optimal glycaemic targets with other classes of glucose-lowering therapies. Since the introduction of insulin analogues, insulin management has changed. This follow-up review attempts to update our earlier publication from 2009 and discusses the role of new insulin analogues and newer insulin regimens. Recognising the advent of new quality and economic initiatives both in the UK and worldwide, this paper reviews current insulin prescribing and the pros and cons of prescribing analogues in comparison to the human insulins that are now gaining more acceptance in everyday clinical practice.
机译：糖尿病患者早期良好的血糖控制的遗留效应表明它与减少微血管和大血管并发症有关。对于1型糖尿病患者来说，胰岛素治疗至关重要且可以挽救生命，对于其他类型的降糖治疗未能达到最佳血糖目标的2型糖尿病患者而言，胰岛素治疗是有益的。自从引入胰岛素类似物以来，胰岛素管理发生了变化。这项后续审查试图更新我们从2009年开始的出版物，并讨论新的胰岛素类似物和新的胰岛素治疗方案的作用。认识到英国和世界范围内新的质量和经济措施的问世，本文与目前在日常临床实践中越来越被人们接受的人胰岛素相比，回顾了目前的胰岛素处方以及类似药物处方的利弊。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号